Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

Platinum-Based Drugs in Cancer Therapy, Paperback / softback Book

Platinum-Based Drugs in Cancer Therapy Paperback / softback

Edited by Lloyd R. Kelland, Nicholas P. Farrell

Part of the Cancer Drug Discovery and Development series

Paperback / softback

Description

Leading international experts comprehensively review all aspects of platinum anticancer drugs and their current use in treatment, as well as examining their future therapeutic prospects.

Writing from a variety of disciplines, these authorities discuss the chemistry of cisplatin in aqueous solution, the molecular interaction of platinum drugs with DNA, and such exciting new areas as DNA mismatch repair and replicative bypass, apoptosis, and the transport of platinum drugs into tumor cells.

The emergent platinum drugs of the future-orally active agents, the sterically hindered ZD0473, and the polynuclear charged platinum BBR3464-are also fully considered.

Timely and interdisciplinary, Platinum-Based Drugs in Cancer Therapy offers cancer therapeutics specialists an illuminating survey of every aspect of platinum drugs from mechanisms of action to toxicology, tumor resistance, and new analogs.

Information

Save 11%

£99.99

£88.95

 
Free Home Delivery

on all orders

 
Pick up orders

from local bookshops

Information

Also in the Cancer Drug Discovery and Development series